Kasuwar Organoids tana yin rijista sama da 14% CAGR tsakanin 2021 da 2031

A matsayin sabbin dandamali don haɓakar magunguna cikin sauri da ingantattun tsarin ƙirar ƙima don ƙididdige inganci da guba, organoids suna da yuwuwar yin canji. Hanyoyin gano magungunan gargajiya ba su da mahimmanci kuma basu isa su ci gaba da saurin ci gaban kimiyyar rayuwa ba. Ana hasashen Organoids don nuna karuwar tallace-tallace a cikin masana'antar gano magunguna.

Bukatar yankan-baki na gwajin hanyoyin gwaji ya karu a sakamakon ci gaba a cikin hanyoyin kwantar da hankali na miyagun ƙwayoyi irin su jiyya na keɓaɓɓen magani da faɗaɗa binciken likitanci don gano sabbin magungunan gaba. -vitro' yanayin da ke da ɗan kusanci da yanayin muhalli na halitta.

A cewar Ƙungiyar Ƙasa ta Duniya na Masu Masana'antu da Ƙungiyoyin Magunguna, bincike na gaskiya ya kai kusan kashi 22% na yawan kuɗin da ake samarwa na magunguna. Yin amfani da kwayoyin halitta a cikin ci gaban miyagun ƙwayoyi yana rage tsari kuma yana adana kuɗi, yana haifar da buƙatun kwayoyin halitta.

Dangane da samfur, ana sa ran organoids na hanji za su yi rijistar buƙatu mai yawa, wanda ya kai sama da 36% na tallace-tallace a kasuwa. Yayin da ake sa ran aikace-aikacen organoids zai yi girma sosai a cikin bankin halittu.

Mabuɗin Takeaways daga Nazarin Kasuwar Organoids

• Kasuwar organoids za ta nuna ingantaccen ci gaba, yin rijista sama da 14% CAGR tsakanin 2021 da 2031
• Fadada sashin magunguna da saka hannun jari a shirye-shiryen bincike zai ba da damar asusun Amurka sama da kashi 95% na tallace-tallace a Arewacin Amurka
• Burtaniya za ta fito a matsayin babbar kasuwa, tana nuna haɓakar haɓakar yoy sama da 20% a cikin 2021
• Ana sa ran Jamus da Faransa za su fito a matsayin wasu kasuwanni masu fa'ida a cikin Burtaniya
• Kasar Sin za ta ci gaba da kasancewa babbar kasuwa ga kwayoyin cuta a Gabashin Asiya, duk da haka, kasuwar Japan za ta yi rajistar dan kadan mafi girma na girma

"Irin al'adun 3D-organoid don kwaikwayi aikin gabobin jiki da kuma haɓaka karɓar fasahar organoid don amfani da su a cikin aikace-aikace da yawa, gami da maye gurbin kwayoyin halitta da sauran abubuwan ana tsammanin za su haifar da haɓakar kasuwar Organoids" in ji Manazarcin FMI.

Don ci gaba da gaban masu fafatawa, nemi samfurin - https://www.futuremarketinsights.com/reports/sample/rep-gb-8106

Bayar da kuɗi don bincike na kimiyyar rayuwa da saka hannun jari a samfuran Organoids don faɗaɗa ayyuka daban-daban da ma'aikata shine babban abin da ake tsammanin zai haɓaka haɓakar kasuwancin organoids.

Misali, adadin tallafin bincike da Cibiyar Kiwon Lafiya ta Kasa (NIH) ta bayar a Amurka ya zarce dalar Amurka miliyan 251 cikin shekaru biyar (2015 zuwa 2019).

Manyan 'yan wasa a cikin Organoids suna Shiga cikin Ƙungiyoyin DabarunManyan ƴan wasan suna mai da hankali kan faɗaɗa sawun kasuwancin su ta hanyar saye. Saye-shaye suna ba wa kamfani ƙarfi mai ƙarfi na sabbin samfura, alaƙar masu siye, da sabbin hangen nesa don samun damar kasuwa. Manyan masana'antun suna yin niyya don siyan sanannun samfura da fasahohin da ake sa ran samun nasarar hanyar samun kudaden shiga. Wannan kuma yana taimakawa kasuwancin don haɓaka zuwa sabbin kasuwanni masu tasowa tare da haɓaka waɗanda suke.

Misali, a cikin watan Satumba na shekarar 2020, BGI-Qingdao da Ubrecht Organoid Technology (HUB) suka rattaba hannu kan wata yarjejeniya ta fahimtar juna don samar da cibiyar hadin gwiwa ta Next Generation Diagnostics (NGD) a kasar Sin don inganta keɓaɓɓen kulawa, ingantattun jiyya da magunguna. da saurin haɓaka sabbin magunguna masu aminci.HUB da BGI za su haɗu da ƙwarewar ƙwarewarsu da fasaha don ƙara haɓakawa da haɗa fasahar HUB Organoid azaman gwajin tsinkaya, ba da damar ingantaccen tsinkayar amsawar jiyya ta musamman na haƙuri, da farko tare da mai da hankali kan ciwon daji.

Sakamakon karuwar girmamawa kan binciken ilimin oncology da haɓaka kashe kuɗi na R&D, ana sa ran kasuwar organoids ta duniya za ta faɗaɗa cikin lokacin hasashen. Kasuwancin Organoids yana da matukar fa'ida da ke nuna kasancewar 'yan wasa da yawa. Saboda babban jarin jarin da ake buƙata don gina ginin masana'antar Organoids, kamfanonin harhada magunguna suna ƙara neman fitar da tsarin.Mahimman 'yan kasuwar da FMI ke rufewa sun haɗa da STEMCELL Technologies Inc., Cellesce Ltd., DefiniGEN, Qgel, Hubrecht Organoid Technology, OcellO BV yana haɓaka matsayinsu ta hanyar haɗaka, saye da sabbin samfuran ƙaddamarwa.

Fahimtar Fahimtar Kasuwar OrganoidsHasashen Kasuwa na gaba, a cikin sabon sadaukarwarsa, yana ba da nazarin rashin son rai na kasuwar organoids, yana gabatar da bayanan buƙatun tarihi (2016-2020) da kididdigar hasashen lokacin daga 2021-2031. Binciken ya ba da haske mai gamsarwa kan kasuwa dangane da nau'in samfur (kwayoyin hanji, gabobin hanta, gabobin pancreatic organoids, organoids masu launin launi, da kwayoyin jijiyoyi), aikace-aikacen (bio-banking, binciken ilimin halittu da gano magunguna, magunguna masu sabuntawa, binciken kansa, da warkewa). kayan aikin), da kuma mai amfani na ƙarshe (kamfanonin biopharmaceutical, ƙungiyoyin bincike na kwangila, da masana kimiyya da cibiyoyin bincike) a cikin manyan yankuna bakwai.

Kasuwar Organoids ta CategoryTa Nau'in Samfur, kasuwar Organoids ta kasu kashi kamar:

• Organoids na hanji
• Hepatic Organoids
• Pancreatic Organoids
• Colorectal Organoids
• Jijiya Organoids
• wasu

Ta Aikace-aikacen, Kasuwancin Organoids ya kasu kashi kamar:

• Bio-banking
• Binciken Halittu da Gano Magunguna
• Medicine Regenerative
• Cibiyar Cancer
• Kayayyakin warkewa
• wasu

Ta Ƙarshen Mai amfani, kasuwar Organoids ta kasu kashi kamar:

• Kamfanonin Biopharmaceutical
• Ƙungiyoyin Binciken Kwangiloli
• Makarantun Ilimi da Cibiyoyin Bincike

Ta Yanki, kasuwar Organoids ta rabu kamar:

• Amirka ta Arewa
• Latin America
• Turai
• East Asia
• Kudancin Asia
• Oceania
• Gabas ta Tsakiya da Afirka (MEA)

Sami Rahoton da aka Keɓance don Daidaita buƙatun ku, Tambayi daga Masanin Binciken Kasuwa - https://www.futuremarketinsights.com/ask-question/rep-gb-8106